Oxygen Therapy for Overactive Cells in Type 2 Diabetes

can⁣ Breathing High-Oxygen Air Help Manage Type 2 Diabetes?

New research from teh University of Missouri explores the potential of oxygen therapy to⁢ target overactive‍ cells linked to ⁣metabolic disorders.

Could simply breathing in more oxygen offer a new‍ avenue for managing type 2 diabetes?⁤ Researchers at the University of Missouri are investigating this intriguing possibility by focusing on specialized cells called peripheral chemoreceptors. These cells, found throughout the body, act as ⁣oxygen sensors, playing a crucial role in regulating breathing and blood pressure.

“Exciting studies in rats have shown that removing these overactive chemoreceptors can improve issues⁤ like high blood ⁢pressure and high blood sugar,” explains Jacqueline Limberg, associate professor of nutrition and exercise physiology and lead author of the study.”We ‍wondered if manipulating oxygen levels,specifically by increasing them,might have a similar effect in humans.”

The research team recruited 37 participants, including 17 adults with type 2 diabetes and 20 healthy individuals as a control group.Their findings revealed that peripheral chemoreceptors were indeed more active in those with diabetes, with ⁤the highest activity levels observed in patients with the highest blood sugar.

Participants then underwent a period of hyperoxia, where they breathed in air with a higher-then-normal oxygen concentration. This resulted in a decrease in chemoreceptor activity, along with reductions in heart rate, blood pressure, and breathing rate. Interestingly, these effects were observed⁤ in both groups, regardless ‍of diabetes status. However, the study did not find any immediate improvements in glucose tolerance or insulin sensitivity.

“While a single⁢ session of hyperoxia⁣ didn’t lead to immediate metabolic improvements, this research ⁤provides valuable insights into the complex relationship between oxygen sensing, chemoreceptor activity, and type 2 diabetes,” says Camila Manrique-Acevedo, ⁤professor of medicine ⁣and co-author of the study. “This knowledge will help us focus on developing ‍more effective therapies for patients with type 2 diabetes.”

The University of Missouri team plans to continue exploring the potential of targeting chemoreceptors for diabetes management, investigating longer-term ⁢effects of oxygen therapy and other innovative approaches.

can Breathing⁢ High-Oxygen Air Help Manage Type 2 Diabetes?

New research from the University of Missouri explores the potential⁢ of oxygen therapy to⁤ target overactive cells linked to metabolic disorders.

Exciting new research from the University of Missouri is exploring whether breathing in high-oxygen air could offer a novel approach ‍to managing‍ type 2 ⁤diabetes. The study, led by associate professor ⁣of nutrition and‍ exercise physiology Jacqueline Limberg, focuses on specialized cells called peripheral chemoreceptors.

These oxygen-sensing cells, found throughout the body, play a crucial role in regulating breathing and blood pressure. previous studies in rats⁢ showed that removing these overactive chemoreceptors improved high blood pressure and high blood sugar ‍levels.

“We wondered if manipulating oxygen levels,specifically⁢ by increasing ⁣them,might have ‍a similar effect in humans,” explains Limberg.

The team studied 37 participants,⁢ including 17 adults with type 2 diabetes and⁣ 20 healthy controls.

Thier findings revealed that peripheral chemoreceptors were indeed more active in those with diabetes, with activity levels directly correlating with blood sugar levels.

Participants then underwent a hyperoxia session, breathing air with a higher-than-normal oxygen concentration. This resulted ⁣in a decrease in chemoreceptor activity, along with reductions in heart rate, ⁤blood pressure,⁢ and breathing rate.

Interestingly, these positive effects were observed in both groups, ⁢regardless of diabetes status. However, the study did not find any immediate improvements in glucose tolerance or insulin sensitivity.

“While a single session of hyperoxia didn’t led ‍to immediate metabolic improvements, this research provides valuable insights into the complex ‍relationship between oxygen sensing, chemoreceptor‍ activity, and type 2 diabetes,” says camila Manrique-Acevedo, professor of medicine and co-author of the study. “This knowledge will help us focus on developing more effective⁢ therapies for patients with⁢ type⁤ 2 diabetes.”

The University⁣ of Missouri team plans ⁤to continue exploring the potential of⁣ targeting chemoreceptors for ‍diabetes management, investigating longer-term effects of oxygen⁣ therapy and other innovative⁤ approaches.